Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

TRIB

Trinity Biotech plc

Healthcare · USD

Set alert

Price alert · TRIB

All alert types
6.26 USD -0.37 -5.58%
As of Oct 30, 2026 Extended hours 6.71 +7.24%
Bid
6.26 × 1
Ask
6.53 × 2
6.26 Day range 6.43
5.69 52-week range 38.40
YTD
-73.59%
1 year
-79.13%
Open
6.43
Prev close
6.63
Mkt cap
5.09M
Vol
6.70K
Avg vol
19.14K
EPS
-60.00
P/E
0.00
Div yield
0.00%
More statistics
Low
6.26
High
6.43
Forward P/E
-0.87
Beta
1.13
Short ratio
0.43
Inst. own
23.96%
Dividend
0.00
Ex-div date
Jun 4, 2015
50-d avg
1.39
200-d avg
1.90
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for TRIB has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.18 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -0.4×
FY 2016: -1.6×FY 2017: -2.8×FY 2018: 20.1×FY 2019: -5.3×FY 2020: -12.4×FY 2021: 34.0×FY 2022: -0.8×FY 2023: -0.7×FY 2024: -0.5×FY 2025: -0.4×
FY 2016 5y median -0.5× FY 2025
P/S 0.3×
FY 2016: 1.6×FY 2017: 1.1×FY 2018: 0.5×FY 2019: 0.2×FY 2020: 0.8×FY 2021: 0.4×FY 2022: 0.5×FY 2023: 0.3×FY 2024: 0.3×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
P/B -0.2×
FY 2016: 1.5×FY 2017: 1.7×FY 2018: 1.1×FY 2019: 4.6×FY 2020: -35.9×FY 2021: -93.7×FY 2022: -15.3×FY 2023: -0.7×FY 2024: -0.4×FY 2025: -0.2×
FY 2016 5y median -0.7× FY 2025
P/FCF -1.2×
FY 2016: -18.7×FY 2017: -26.3×FY 2018: -4.6×FY 2019: -2.2×FY 2020: 5.9×FY 2021: 6.6×FY 2022: -4.8×FY 2023: -1.3×FY 2024: -1.1×FY 2025: -1.2×
FY 2016 5y median -1.2× FY 2025
EV/EBITDA -6.9×
FY 2016: -5.8×FY 2017: -5.1×FY 2018: -7.1×FY 2019: -5.5×FY 2020: 49.0×FY 2021: 9.7×FY 2022: -5.9×FY 2023: -3.3×FY 2024: -6.6×FY 2025: -6.9×
FY 2016 5y median -5.9× FY 2025
EV/Sales 3.4×
FY 2016: 1.8×FY 2017: 1.5×FY 2018: 1.0×FY 2019: 1.2×FY 2020: 1.5×FY 2021: 1.3×FY 2022: 1.6×FY 2023: 1.4×FY 2024: 1.8×FY 2025: 3.4×
FY 2016 5y median 1.6× FY 2025
FCF Yield -82.7%
FY 2016: -5.4%FY 2017: -3.8%FY 2018: -21.6%FY 2019: -45.7%FY 2020: 17.0%FY 2021: 15.2%FY 2022: -20.7%FY 2023: -75.1%FY 2024: -90.2%FY 2025: -82.7%
FY 2016 5y median -75.1% FY 2025

Profitability

Gross Margin 38.6%
FY 2016: 43.3%FY 2017: 42.3%FY 2018: 42.7%FY 2019: 42.2%FY 2020: 47.6%FY 2021: 41.2%FY 2022: 35.3%FY 2023: 34.2%FY 2024: 34.8%FY 2025: 38.6%
FY 2016 5y median 35.3% FY 2025
Operating Margin -26.1%
FY 2016: 7.5%FY 2017: 5.5%FY 2018: 3.4%FY 2019: 1.0%FY 2020: 0.1%FY 2021: 4.9%FY 2022: -24.4%FY 2023: -47.6%FY 2024: -34.4%FY 2025: -26.1%
FY 2016 5y median -26.1% FY 2025
Net Margin -85.4%
FY 2016: -101.0%FY 2017: -40.6%FY 2018: 2.5%FY 2019: -4.5%FY 2020: -6.3%FY 2021: 1.1%FY 2022: -65.6%FY 2023: -42.3%FY 2024: -51.6%FY 2025: -85.4%
FY 2016 5y median -51.6% FY 2025
ROE 51.9%
FY 2016: -92.5%FY 2017: -61.8%FY 2018: 5.4%FY 2019: -86.3%FY 2020: 287.9%FY 2021: -274.3%FY 2022: 1884.3%FY 2023: 100.3%FY 2024: 90.4%FY 2025: 51.9%
FY 2016 5y median 90.4% FY 2025
ROIC -15.3%
FY 2016: 3.3%FY 2017: 3.2%FY 2018: 1.9%FY 2019: -3.8%FY 2020: 0.1%FY 2021: 3.7%FY 2022: -19.8%FY 2023: -58.3%FY 2024: -28.7%FY 2025: -15.3%
FY 2016 5y median -19.8% FY 2025
ROA -35.5%
FY 2016: -40.3%FY 2017: -20.9%FY 2018: 1.6%FY 2019: -3.1%FY 2020: -4.9%FY 2021: 0.7%FY 2022: -44.5%FY 2023: -40.4%FY 2024: -30.8%FY 2025: -35.5%
FY 2016 5y median -35.5% FY 2025

Growth (YoY)

Revenue -28.9%
FY 2016: -0.6%FY 2017: -0.5%FY 2018: -2.1%FY 2019: -6.8%FY 2020: 12.8%FY 2021: -20.4%FY 2022: -23.0%FY 2023: -9.1%FY 2024: 8.3%FY 2025: -28.9%
FY 2016 FY 2025
Operating Income 46.1%
FY 2016: -44.3%FY 2017: -26.9%FY 2018: -39.8%FY 2019: -73.6%FY 2020: -90.6%FY 2021: 4702.4%FY 2022: -487.7%FY 2023: -77.1%FY 2024: 21.7%FY 2025: 46.1%
FY 2016 FY 2025
EPS (diluted) -13.3%
FY 2016: -3804.2%FY 2017: 57.9%FY 2018: 106.1%FY 2019: -273.9%FY 2020: -92.3%FY 2021: 110.7%FY 2022: -3270.7%FY 2023: 38.5%FY 2024: 44.8%FY 2025: -13.3%
FY 2016 FY 2025
Free Cash Flow 14.8%
FY 2016: 18.1%FY 2017: 50.0%FY 2018: -143.3%FY 2019: 4.5%FY 2020: 237.2%FY 2021: -66.5%FY 2022: -251.7%FY 2023: -79.2%FY 2024: -15.3%FY 2025: 14.8%
FY 2016 FY 2025

Financial Health

Current Ratio 0.3×
FY 2016: 5.3×FY 2017: 5.3×FY 2018: 4.9×FY 2019: 3.7×FY 2020: 3.1×FY 2021: 0.7×FY 2022: 2.7×FY 2023: 2.6×FY 2024: 1.3×FY 2025: 0.3×
FY 2016 5y median 1.3× FY 2025
Quick Ratio 0.1×
FY 2016: 4.0×FY 2017: 3.8×FY 2018: 3.2×FY 2019: 2.0×FY 2020: 2.0×FY 2021: 0.4×FY 2022: 1.4×FY 2023: 1.3×FY 2024: 0.7×FY 2025: 0.1×
FY 2016 5y median 0.7× FY 2025
Debt / Equity -1.9×
FY 2016: 0.9×FY 2017: 1.5×FY 2018: 1.9×FY 2019: 21.7×FY 2020: -47.0×FY 2021: -311×FY 2022: -33.2×FY 2023: -2.8×FY 2024: -2.9×FY 2025: -1.9×
FY 2016 5y median -2.9× FY 2025
Net Debt / EBITDA -6.2×
FY 2016: -0.6×FY 2017: -1.3×FY 2018: -3.7×FY 2019: -4.4×FY 2020: 24.1×FY 2021: 6.9×FY 2022: -3.9×FY 2023: -2.6×FY 2024: -5.7×FY 2025: -6.2×
FY 2016 5y median -3.9× FY 2025
Interest Coverage -0.9×
FY 2016: 1.6×FY 2017: 1.0×FY 2018: 0.6×FY 2019: 0.2×FY 2020: 0.0×FY 2021: 0.6×FY 2022: -0.6×FY 2023: -2.7×FY 2024: -2.2×FY 2025: -0.9×
FY 2016 5y median -0.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31